S&P 500   2,988.82 (-0.23%)
DOW   27,012.75 (-0.04%)
QQQ   192.82 (-0.36%)
AAPL   233.82 (-0.64%)
FB   188.86 (-0.02%)
MSFT   140.05 (-1.07%)
GOOGL   1,244.60 (+0.19%)
AMZN   1,776.74 (+0.53%)
NVDA   195.57 (-0.41%)
MU   45.63 (-1.77%)
BABA   176.35 (+0.60%)
GE   8.94 (+0.45%)
TSLA   260.21 (+0.90%)
AMD   30.92 (+0.65%)
F   9.11 (+0.44%)
ACB   3.71 (-1.33%)
GILD   65.64 (+0.52%)
DIS   131.15 (+1.07%)
S&P 500   2,988.82 (-0.23%)
DOW   27,012.75 (-0.04%)
QQQ   192.82 (-0.36%)
AAPL   233.82 (-0.64%)
FB   188.86 (-0.02%)
MSFT   140.05 (-1.07%)
GOOGL   1,244.60 (+0.19%)
AMZN   1,776.74 (+0.53%)
NVDA   195.57 (-0.41%)
MU   45.63 (-1.77%)
BABA   176.35 (+0.60%)
GE   8.94 (+0.45%)
TSLA   260.21 (+0.90%)
AMD   30.92 (+0.65%)
F   9.11 (+0.44%)
ACB   3.71 (-1.33%)
GILD   65.64 (+0.52%)
DIS   131.15 (+1.07%)
Log in

Core Laboratories Stock Price, News & Analysis (NYSE:CLB)

+0.07 (+0.16 %)
(As of 10/16/2019 01:45 PM ET)
Today's Range
Now: $44.62
50-Day Range
MA: $44.38
52-Week Range
Now: $44.62
Volume284,497 shs
Average Volume654,425 shs
Market Capitalization$1.98 billion
P/E Ratio19.57
Dividend Yield4.98%
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. Read More…

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified



Sales & Book Value

Annual Sales$700.85 million
Cash Flow$2.84 per share
Book Value$3.64 per share


Net Income$79.52 million


Market Cap$1.98 billion
Next Earnings Date10/23/2019 (Confirmed)

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Tuesday, October 8th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.55 per share on Tuesday, November 19th. This represents a $2.20 annualized dividend and a yield of 4.85%. The ex-dividend date is Thursday, October 17th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its earnings results on Wednesday, July, 24th. The oil and gas company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The oil and gas company had revenue of $169.04 million for the quarter, compared to the consensus estimate of $173.46 million. Core Laboratories had a return on equity of 51.19% and a net margin of 14.30%. The company's quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.59 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Core Laboratories.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.50. The company issued revenue guidance of $171-175 million, compared to the consensus revenue estimate of $179.03 million.

What price target have analysts set for CLB?

13 equities research analysts have issued 12-month price objectives for Core Laboratories' stock. Their forecasts range from $51.00 to $120.00. On average, they anticipate Core Laboratories' share price to reach $72.82 in the next year. This suggests a possible upside of 60.7% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

News stories about CLB stock have been trending neutral recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Core Laboratories earned a news sentiment score of 0.4 on InfoTrie's scale. They also assigned news stories about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Core Laboratories.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest in September. As of September 30th, there was short interest totalling 3,340,000 shares, an increase of 16.8% from the August 30th total of 2,860,000 shares. Based on an average daily volume of 694,100 shares, the days-to-cover ratio is presently 4.8 days. Approximately 7.7% of the company's stock are short sold. View Core Laboratories' Current Options Chain.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Micron Technology (MU), Starbucks (SBUX), Baidu (BIDU), Athabasca Oil (ATH), NIC (EGOV) and Netflix (NFLX).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Manning & Napier Group LLC (1.80%), Douglas Lane & Associates LLC (0.38%), Scout Investments Inc. (0.17%), Gofen & Glossberg LLC IL (0.06%), Forte Capital LLC ADV (0.04%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Gofen & Glossberg LLC IL, Forte Capital LLC ADV and Financial Gravity Wealth Inc.. View Insider Buying and Selling for Core Laboratories.

Which institutional investors are buying Core Laboratories stock?

CLB stock was bought by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Douglas Lane & Associates LLC and State of Alaska Department of Revenue. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $45.32.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $2.01 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com/.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  422 (Vote Outperform)
Underperform Votes:  558 (Vote Underperform)
Total Votes:  980
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Front-End Load

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel